| Not Yet Recruiting | A Study to Assess Real-world Outcomes for Long-Term Use of Guselkumab NCT07532213 | Janssen-Cilag A.G., Switzerland | — |
| Not Yet Recruiting | The EDICT Trial - Therapy for Inflammatory Bowel Disease Flares NCT07143188 | Wake Forest University Health Sciences | N/A |
| Recruiting | Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inf NCT07210580 | VA Office of Research and Development | N/A |
| Recruiting | Impact of Morning Light Therapy in IBD NCT07207200 | Icahn School of Medicine at Mount Sinai | N/A |
| Not Yet Recruiting | Integrating Vaccination Into Hospital Care Pathways for Vulnerable Patients NCT07391046 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Enrolling By Invitation | Continuous HRV Monitoring for Predicting Response to Biologic Therapy in IBD NCT07475052 | Xijing Hospital | — |
| Enrolling By Invitation | Automated Clinical Pathway for Inflammatory Bowel Disease Care NCT07167836 | University of Texas Southwestern Medical Center | N/A |
| Recruiting | A Study to Observe Real-world Evidence of Guselkumab Treatment in Participants With Ulcerative Colitis and Cro NCT07242248 | Janssen-Cilag Ltd. | — |
| Completed | A Clinical Study to Evaluate SM17 in Healthy Participants NCT07466940 | SinoMab BioScience Ltd | Phase 1 |
| Recruiting | A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in Germany NCT07102368 | Janssen-Cilag G.m.b.H | — |
| Completed | Tracking the Natural Course of Silent Small Bowel Narrowing in Adults With Crohn's Disease NCT07167745 | University Medical Center Zvezdara | — |
| Not Yet Recruiting | LMT503 First-in-human SAD, MAD, and FE Study NCT05659953 | Lmito Therapeutics Inc. | Phase 1 |
| Recruiting | Gut Microbiota in IBD With Comorbid Depressive Disorder NCT07252427 | Fang Tang | — |
| Not Yet Recruiting | Whey Protein Milk-Derived Exosomes NCT06755021 | Exosomm Ltd. | N/A |
| Recruiting | Research on the Use of Probiotics in the Prevention and Treatment of Inflammatory Bowel Disease NCT06781827 | Wecare Probiotics Co., Ltd. | N/A |
| Recruiting | COVID-19 Booster and IIV Schedule in Immunocompromised Hosts NCT06599658 | McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 2 |
| Not Yet Recruiting | Correlation of Fecal Calprotectin and Fecal Immunochemical Test in Determination of Endoscopic Activity in Inf NCT06623383 | Mahidol University | — |
| Not Yet Recruiting | Impact of Primary Language on Treatment and Outcomes in Inflammatory Bowel Disease NCT06405503 | University of Texas at Austin | — |
| Recruiting | A Clinical Study of SPH7854 Granules in Healthy Subjects. NCT06483373 | Shanghai Pharmaceuticals Holding Co., Ltd | EARLY_Phase 1 |
| Completed | A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflamma NCT06346288 | AbbVie | Phase 4 |
| Recruiting | Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease NCT06780683 | Xiang Gao | — |
| Unknown | A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safet NCT06175949 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Unknown | EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD NCT06321887 | Liverpool University Hospitals NHS Foundation Trust | Phase 3 |
| Withdrawn | Natural History of Intestinal Inflammation in People With Primary Immune Dysregulations NCT03278912 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Recruiting | Effect of Mediterranean Diet in Inflammatory Bowel Disease NCT05973500 | University of California, San Diego | N/A |
| Recruiting | Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal Inflam NCT06001450 | Icahn School of Medicine at Mount Sinai | — |
| Active Not Recruiting | Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in R NCT05633771 | Sandoz | — |
| Withdrawn | The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel D NCT05652491 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect. NCT05638347 | Atridia Pty Ltd. | Phase 1 |
| Terminated | Reduce Crohn's-Associated Diarrhea With Sodium Channel Therapy NCT04456517 | Vanderbilt University Medical Center | Phase 2 |
| Recruiting | A Randomized Crossover Trial of Bright Light Therapy in Crohn's Disease on Intestinal Barrier Homeostasis NCT05579392 | Rush University Medical Center | N/A |
| Unknown | Efficacy of Energy Therapy in the Management of Chronic Pain Medical Condition in Children and Adolescents. NCT05394272 | King's College Hospital NHS Trust | N/A |
| Recruiting | Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidat NCT04751396 | M.D. Anderson Cancer Center | — |
| Unknown | Correlation of Genetic Susceptibility Genes to Inflammatory Bowel Disease in Chinese Han Population NCT05071742 | Second Affiliated Hospital of Wenzhou Medical University | — |
| Completed | Evaluation of the Pharmacokinetics, Safety and Tolerability of Single Dose of PF-06480605 in Chinese Healthy P NCT05107492 | Pfizer | Phase 1 |
| Recruiting | Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut Uni NCT05002166 | Assiut University | — |
| Completed | Elemental Diet for Treatment of Inflammatory Bowel Disease in Patients With Chronic Granulomatous Disease NCT03983837 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Terminated | Health-Related Quality of Life in Crohn's Disease Participants With Complex Perianal Fistula Before and After NCT04102163 | Takeda | — |
| Recruiting | The Influence of a Fasting Mimicking Diet on Ulcerative Colitis NCT03615690 | Stanford University | N/A |
| Withdrawn | Distribution of a Single IV Dose Of [124I]-Pf 06687234 and Pf 06687234 Assessed With PET-CT Imaging In Moderat NCT03414788 | Pfizer | Phase 1 |
| Recruiting | High Dose Interval Vitamin D Supplementation in Patients With Inflammatory Bowel Disease Receiving Biologic Th NCT04331639 | Boston Children's Hospital | — |
| Completed | Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU NCT06031038 | Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa | N/A |
| Recruiting | Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease NCT04508088 | Massachusetts General Hospital | — |
| Unknown | Characterizing Inflammatory Bowel Disease With 68Ga-FAPI PET/CT NCT04507932 | Peking Union Medical College Hospital | EARLY_Phase 1 |
| Unknown | Inflammatory Bowel Disease (IBD) and Covid-19 Infection NCT04492267 | University Hospital, Strasbourg, France | — |
| Completed | ENhanced Recovery in CHildren Undergoing Surgery NCT04060303 | Northwestern University | Phase 3 |
| Unknown | Changes of Muramyl Dipeptide in Intestinal and Extra-intestinal Diseases NCT04924686 | Zhujiang Hospital | — |
| Withdrawn | Resistance Training Intervention to Promote Lean Mass in Youth With IBD NCT04017637 | University of Alabama at Birmingham | N/A |
| Unknown | Effect of Standardized Nutritional Therapy on Clinical Prognosis and Cost-effectiveness of Inflammatory Bowel NCT04349943 | The Third Xiangya Hospital of Central South University | N/A |
| Completed | Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis NCT03881436 | IHU Strasbourg | N/A |
| Recruiting | Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorde NCT03816345 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Perianal Fistula (PAF) Validation and Burden of Illness Study NCT03981939 | Takeda | — |
| Completed | Specialty Medical Homes to Improve Outcomes for Patients With IBD and Behavioral Health Conditions NCT03985800 | University of Pittsburgh | N/A |
| Recruiting | Health and Exercise Response in Children With Chronic and Auto-immune Pathologies NCT03913962 | University Hospital, Clermont-Ferrand | N/A |
| Unknown | Managing Stress With Inflammatory Bowel Disease NCT03852745 | University of Manitoba | N/A |
| Completed | A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants NCT03488030 | Takeda | — |
| Unknown | Improving Outcomes Among Urgent Care Clinic Patients With Inflammatory Bowel Disease NCT03239704 | Mount Sinai Hospital, Canada | N/A |
| Completed | Inflammatory Bowel Disease : Could a Regular Physical Activity Reduce Patients Fatigue ? NCT02861053 | University Hospital, Rouen | N/A |
| Completed | Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study NCT03555617 | Theravance Biopharma | Phase 1 |
| Unknown | Analysis of Volatile Organic Compounds in the Exhaled Air in Inflammatory Bowel Disease NCT03414580 | Keimyung University Dongsan Medical Center | — |
| Unknown | Contrast-enhanced Bowel Ultrasound in Making a Diagnosis and Follow-up of Patients With Inflammatory Bowel Dis NCT03744130 | State Scientific Centre of Coloproctology, Russian Federation | N/A |
| Completed | A Trial of Yoga in Pediatric Inflammatory Bowel Disease NCT03338894 | Atlantic Health System | N/A |
| Completed | Study to Observe the Change in Microbiome in Human Derived Sample and the Relation With Clinical Response Befo NCT03264690 | Eisai Korea Inc. | — |
| Terminated | Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflam NCT03201445 | Galapagos NV | Phase 2 |
| Completed | GIS-SUSANTI-TNF-2015 (Anti-TNF Discontinuation ) NCT02994836 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | Phase 4 |
| Completed | Tailored Transition for IBD Adolescents NCT02893670 | Schneider Children's Medical Center, Israel | N/A |
| Withdrawn | Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subj NCT03035058 | Takeda | Phase 3 |
| Unknown | PhaseⅠFirst-in-Human Study of Hemay007 in Healthy Volunteers NCT02603185 | Hemay Pharmaceutical PTY. LTD. | Phase 1 |
| Completed | Predicting Response to Vedolizumab in Pediatric Inflammatory Bowel Diseases NCT02862132 | Shaare Zedek Medical Center | N/A |
| Completed | An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain NCT02686892 | Javier P. Gisbert | — |
| Completed | Early Biomarkers in Circulating α 4β7 + T Cells to Predict Response to Vedolizumab in Inflamatory Bowel Diseas NCT02712866 | Parc de Salut Mar | — |
| Completed | Inflammatory Bowel Disease in South Eastern Norway NCT02727959 | Oslo University Hospital | — |
| Unknown | Fatigue Management in Quiescent IBD NCT02709434 | The Leeds Teaching Hospitals NHS Trust | N/A |
| Unknown | Cytokine Production of Colonic Tissue From IBD Patients NCT02828748 | Meir Medical Center | N/A |
| Completed | A Retrospective Observational Study to Assess the Impact of Co-morbidities on Treatment Response in Inflammato NCT02861118 | Takeda | — |
| Completed | Non-interventional Study of Moderate to Severe Inflammatory Bowel Disease in Brazil NCT02822235 | Takeda | — |
| Unknown | Assessment of Handgrip Strength in Adults With Inflammatory Bowel Disease NCT02950779 | University of Southampton | — |
| Withdrawn | Managing Infliximab Reinduction After Temporary Discontinuation of Drug NCT02771457 | NYU Langone Health | Phase 3 |
| Completed | Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease NCT02846961 | Kyungpook National University Hospital | — |
| Withdrawn | Integrated Behavioral Health Innovations in Childhood Chronic Illness Care Delivery Systems NCT02740309 | NYU Langone Health | N/A |
| Completed | Ex-vivo Modulatory Effect of Biological Drugs for Inflammatory Bowel Disease on the Mucosa and on Peripheral B NCT03043677 | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa | — |
| Unknown | Trial of Captafer® vs. Oral Iron Sulfate in the Treatment of Iron Deficiency Anemia in Patients With IBD NCT02774057 | American University of Beirut Medical Center | Phase 4 |
| Unknown | Evolution of Lymphocyte Populations Under Biotherapy in Inflammatory Bowel Disease NCT02693340 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | Phenotyping IBS: Perceptions and Modulations of Visceral Sensations NCT02693730 | University of California, Los Angeles | — |
| Completed | Safety and Efficacy Study of Oral Ferric Maltol Compared to Intravenous Iron To Treat Iron Deficiency Anaemia NCT02680756 | Shield Therapeutics | Phase 3 |
| Completed | Quality Of LIfe Tool for IBD NCT02707068 | King's College London | N/A |
| Completed | Electroacupuncture vs. Sham Electroacupuncture for Treatment of Fatigue in Patients With Inflammatory Bowel Di NCT02733276 | Corporacion Parc Tauli | N/A |
| Unknown | 3D Laparoscopy Versus 2D Laparoscopy NCT02841657 | Casa di Cura Dott. Pederzoli | — |
| Enrolling By Invitation | Fecal Microbiome Transplant NCT02636517 | Judith Kelsen | Phase 1 |
| Unknown | The Role of Indocyanine Green (ICG) Fluorescence Imaging on Anastomotic Leak in Robotic Colorectal Surgery NCT02598414 | Acibadem University | Phase 2 / Phase 3 |
| Completed | Pediatric FEcal Microbiota Transplant for Ulcerative Colitis NCT02487238 | McMaster Children's Hospital | Phase 1 |
| Completed | Biomarkers in Inflammatory Bowel Diseases NCT02612103 | Line Elberg Godskesen | — |
| Completed | Virtual Chromoendoscopy for Colitis Surveillance: A Feasibility Study NCT02543021 | King's College Hospital NHS Trust | N/A |
| Completed | Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease NCT02984059 | Connecticut Children's Medical Center | — |
| Completed | IDeaL Pilot Study - Infliximab Dose to Level: Pilot Study NCT02847884 | University of Alberta | — |
| Completed | Carbon Dioxide Insufflation Colonoscopy in IBD Patients NCT02563132 | Vitkovice Hospital | N/A |
| Completed | A Comparison of Ultrasound Guided Transversus Abdominis Plane Nerve Block Techniques NCT02538679 | Cedars-Sinai Medical Center | N/A |
| Completed | Does the Microbiome in IBD Change Alongside Special Treatment Scenarios? NCT02526251 | Nordsjaellands Hospital | — |
| Completed | Nutritional Status and Body Composition in Childhood Inflammatory Bowel Disease NCT02704026 | Ankara University | — |
| Completed | A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis NCT02464020 | University of Minnesota | Phase 1 |
| Unknown | Is Relapse Rate Reduced by Home Monitoring of IBD Patients Tightly or on Demand by FC and Disease Activity? NCT02492555 | Nordsjaellands Hospital | N/A |
| Withdrawn | Bone Density in Children With IBD Treated With Amorphous Calcium or Commercial Crystalline Calcium NCT02470663 | Sheba Medical Center | N/A |
| Completed | GRINCH: Groningen Initiative on Reference Intervals in Children NCT02588222 | University Medical Center Groningen | — |
| Completed | Medication Adherence in Patients With Inflammatory Bowel Disease (IBD) NCT02620514 | Emory University | N/A |
| Completed | Acceptance and Commitment Therapy (ACT) in Inflammatory Bowel Disease NCT02350920 | University College Dublin | N/A |
| Completed | The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness NCT02423512 | Icahn School of Medicine at Mount Sinai | — |
| Completed | Fecal Microbiota Transplant for Inflammatory Bowel Disease NCT02460705 | University of California, San Francisco | EARLY_Phase 1 |
| Terminated | The Value of I-Scan and Confocal Laser Endomicroscopy for the Assessment of Chronic Inflammatory Bowel Disease NCT02481687 | University of Medicine and Pharmacy Craiova | — |
| Completed | Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis NCT02438410 | Mayo Clinic | — |
| Terminated | Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator NCT02413047 | Indiana University | N/A |
| Completed | Precision Dosing of Infliximab Versus Conventional Dosing of Infliximab NCT02453776 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Phase 4 |
| Unknown | SSAT 054: Non Genetic Factors in the Pathogenesis of IBD in Twins NCT02383953 | St Stephens Aids Trust | — |
| Completed | Association of Functional Changes in the Brain and the Perception of Pain in Patients With Chronic Inflammator NCT02433470 | Charite University, Berlin, Germany | Phase 2 |
| Terminated | Fecal Transplantation for Inflammatory Bowel Disease NCT02391012 | Meir Medical Center | Phase 1 |
| Terminated | Corticosteroid Dosage for Crohn's Disease Flare NCT02392286 | Yale University | Phase 4 |
| Unknown | A Trial to Determine the Effects of Exercise in Inflammatory Bowel Disease and Rheumatoid Arthritis NCT02463916 | University College Cork | Phase 2 |
| Completed | Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of Life NCT02322307 | Icahn School of Medicine at Mount Sinai | N/A |
| Unknown | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery NCT02426762 | First Affiliated Hospital, Sun Yat-Sen University | Phase 2 |
| Unknown | Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease NCT02335281 | Yanling Wei | Phase 2 |
| Completed | Precision IFX: Using a Dashboard to Individualize Infliximab Dosage NCT02624037 | Icahn School of Medicine at Mount Sinai | N/A |
| Completed | BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS NCT02351635 | Bühlmann Laboratories AG | — |
| Completed | A Study to Investigate Interleukin-6 (IL-6) and IL-6/Soluble IL-6 Receptor (sIL-6R) Complex Levels in Subjects NCT02790281 | Ferring Pharmaceuticals | — |
| Unknown | The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's D NCT02453607 | Ernest Seidman | — |
| Completed | Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease NCT02726243 | Assistance Publique - Hôpitaux de Paris | — |
| Unknown | Esophageal Motility Disease Screening in Patient With Suspicion or Diagnosis of IBD NCT02478944 | University Hospital Erlangen | N/A |
| Completed | Physical Activity and Bone Mineral Density in Children and Adolescents With Chronic Inflammatory Bowel Disease NCT02341742 | University Hospital, Lille | — |
| Unknown | Iron Supplementation in Inflammatory Bowel Disease (IBD) Patients With Chronic Fatigue NCT02517151 | Istituto Clinico Humanitas | Phase 2 |
| Unknown | GI Symptoms and Sleep Disturbances in Patients With Quiescent Crohns Disease NCT02245594 | University of Aarhus | — |
| Unknown | Resting Energy Expenditure and Nutritional Status in IBD NCT02275676 | University Hospital Muenster | — |
| Completed | Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) NCT02503696 | Exact Sciences Corporation | — |
| Completed | Vascular Dysfunction in Paediatric IBD NCT02161640 | Great Ormond Street Hospital for Children NHS Foundation Trust | — |
| Completed | Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD NCT02197780 | University Medical Center Groningen | — |
| Terminated | Study of the Role of Soluble Inhibitor of Interleukin 22, Interleukin 22 Binding Protein (IL-22BP), in Chronic NCT02847052 | Nantes University Hospital | — |
| Completed | The Effects of Physical Activity on Patients With Inflammatory Bowel Disease NCT02222584 | Yonsei University | — |
| Completed | Improving OutcoMes in the Pediatric to Adult Care Transition in Inflammatory Bowel Disease NCT02085083 | Mount Sinai Hospital, Canada | N/A |
| Unknown | The Role of Small Bowel Ultrasound in Initiation of Infliximab in Crohn's Disease Patients NCT02330458 | Cedars-Sinai Medical Center | — |
| Completed | Integrated Care for Inflammatory Bowel Disease Patients in the Netherlands With the Novel Telemedicine Tool my NCT02173002 | Maastricht University Medical Center | N/A |
| Recruiting | Characterization of Phenotype and Genotype of Early Onset Enteropathies NCT02614911 | Imagine Institute | — |
| Completed | Long-term Functional Outcome of Children With Inflammatory Bowel Disease NCT02152241 | University of Manitoba | — |
| Completed | Stress and Personality Profiles in IBD NCT02614014 | Asociación Española de Gastroenterología | N/A |
| Unknown | The Altitude Inflammatory Bowel Disease Study NCT02849821 | University of Zurich | N/A |
| Unknown | Stavanger IBD Study - Cross Sectional NCT02134054 | Helse Stavanger HF | — |
| Completed | Effects of Fasting on Self Efficacy NCT02113111 | Universität Duisburg-Essen | — |
| Completed | Colon Capsule Endoscopy in Children NCT02129972 | Hospices Civils de Lyon | N/A |
| Completed | Comparison of Surveillance Colonoscopy Techniques in Patients With IBD NCT02098798 | University of Calgary | — |
| Completed | Immune Function in Offsprings of Females With Inflammatory Bowel Disease NCT02079441 | Sheba Medical Center | — |
| Completed | Development of 'Emma'--a Pediatric IBD Quiz NCT02065089 | Mayo Clinic | N/A |
| Unknown | Safety of Anti-tumor Necrosis Factor (TNF) Monoclonal Antibodies in Inflammatory Bowel Disease NCT02066272 | Maria Sklodowska-Curie National Research Institute of Oncology | — |
| Unknown | Single-port Versus Conventional Laparoscopic Colorectal Surgery NCT01626963 | North Tees and Hartlepool NHS Foundation Trust | Phase 1 / Phase 2 |
| Completed | Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness NCT02453880 | Stanford University | N/A |
| Completed | Satisfaction With Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl Sedation for Endoscopy NCT01934088 | Copenhagen University Hospital at Herlev | Phase 4 |
| Completed | Transcranial Direct Current Stimulation to Reduce Chronic Pain in Patients With Chronic Inflammatory Bowel Dis NCT02048137 | Charite University, Berlin, Germany | Phase 2 |
| Completed | Genetic, Serological Fecal and Clinical Markers in Siblings of Children With Inflammatory Bowel Disease NCT02181153 | University of Roma La Sapienza | N/A |
| Unknown | Effects of Pectin on Flora Intestinal Colonization and Maintenance After Fecal Transplantation NCT02016469 | Jinling Hospital, China | N/A |
| Completed | Metabolomic Markers of Fatigue in Inflammatory Bowel Disease NCT04191707 | Corporacion Parc Tauli | — |
| Completed | Vaccination Status, Knowledge and Attitude in Korean Patients With IBD NCT01984879 | Asan Medical Center | — |
| Completed | Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease NCT01861288 | Herlev Hospital | — |
| Completed | Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort NCT02502552 | Centre Hospitalier Universitaire de Saint Etienne | — |
| Completed | Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease NCT01854242 | University of Florida | — |
| Completed | Early Serum Infliximab Levels in Severe Ulcerative Colitis. NCT01971814 | University of California, San Francisco | Phase 1 |
| Completed | Faecal Microbiota Transplantation in Ulcerative Colitis NCT01896635 | The University of New South Wales | Phase 2 |
| Completed | Water-aided Colonoscopy in Inflammatory Bowel Disease Patients NCT01933867 | Vitkovice Hospital | N/A |
| Completed | Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound NCT01852760 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | Web-based Monitoring in Children and Adolescents With Inflammatory Bowel Disease NCT01860651 | Hvidovre University Hospital | N/A |
| Completed | Treating Disrupted Sleep in Individuals With Inflammatory Bowel Disease NCT02162862 | Eva Szigethy | Phase 4 |
| Completed | Self-Management Assistance for Recommended Treatment (SMART) Portal NCT01966744 | Children's Hospital Medical Center, Cincinnati | — |
| Completed | Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease NCT02073526 | Oslo University Hospital | — |
| Completed | Low Volume Colon Preparation for IBD NCT02248337 | Luigi Sacco University Hospital | Phase 4 |
| Withdrawn | Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease NCT01810185 | Santa Barbara Cottage Hospital | Phase 2 |
| Completed | Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's Disease NCT01809275 | Qu Biologics Inc. | Phase 1 / Phase 2 |
| Recruiting | Standardized Fecal Microbiota Transplantation for Ulcerative Colitis NCT01790061 | The Second Hospital of Nanjing Medical University | Phase 2 / Phase 3 |
| Terminated | Prevalence and Clinical Course of Chronic Hep B Infection in IBD and Rheumatologic Disease NCT02128503 | Chinese University of Hong Kong | N/A |
| Recruiting | Standardized Fecal Microbiota Transplantation for Crohn&Apos;s Diseases NCT01793831 | The Second Hospital of Nanjing Medical University | N/A |
| Terminated | Bone Marrow Stromal Cells for Inflammatory Bowel Diseases NCT01851343 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Unknown | Effect of FAn-7 in UC Activity NCT01771224 | National Institute of Medical Sciences and Nutrition, Salvador Zubiran | EARLY_Phase 1 |
| Completed | Bacteriotherapy in Pediatric Inflammatory Bowel Disease NCT01757964 | David Suskind | Phase 1 |
| Unknown | Association Between Inflammatory Activities and Gap Density NCT01758926 | Shandong University | — |
| Completed | Diet and Disease Activity in Patients With Inflammatory Bowel Disease NCT01756963 | Maastricht University Medical Center | — |
| Completed | OPERA Database - Crohn's Protocol NCT01720368 | Dartmouth-Hitchcock Medical Center | — |
| Completed | 25-hydroxyvitamin D and Fatigue: The VITALITY Study NCT01718925 | Ostfold Hospital Trust | — |
| Completed | IBD-OPERA Database, UC Protocol NCT01708395 | Dartmouth-Hitchcock Medical Center | — |
| Completed | Trial on Innovative Technologies in Colonoscopy NCT01688557 | Jagiellonian University | N/A |
| Completed | Infliximab IBD Influenza Vaccine Study NCT01666535 | University of Calgary | N/A |
| Completed | FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel D NCT01676324 | University of British Columbia | — |
| Completed | Telemedicine in Patients With Inflammatory Bowel Disease (TELE-IBD) NCT01692743 | University of Maryland, Baltimore | Phase 3 |
| Withdrawn | Vitamin D Treatment in Ulcerative Colitis NCT01640496 | University of Chicago | N/A |
| Recruiting | Investigating Serotonin Signalling in IBD Patients NCT01650311 | McMaster University | — |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of MT-1303 in Subjects With Inflammatory Bow NCT01666327 | Tanabe Pharma Corporation | Phase 1 |
| Unknown | Assessment of Small Intestinal Bowel Epithelial Gaps in Irritable Bowel Syndrome NCT01632488 | Shandong University | — |
| Completed | Iron Isomaltoside 1000 (Monofer®) Administered by a High Dosing Regimen in Subjects With Inflammatory Bowel Di NCT01599702 | Pharmacosmos A/S | Phase 3 |
| Completed | Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Diseas NCT01787825 | Capso Vision, Inc. | N/A |
| Completed | Predictors of Mucosal Healing in Inflammatory Bowel Disease (IBD) Patients Treated With Anti-TNF NCT01605175 | Evangelismos Hospital | — |
| Completed | Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF NCT01605188 | Evangelismos Hospital | — |
| Completed | Hepatitis B Vaccine in Patients With Inflammatory Bowel Disease NCT01531075 | Soroka University Medical Center | N/A |
| Withdrawn | Endoscopy and Endomicroscopy for Assessment of Mucosal Healing in Inflammatory Bowel Disease (IBD) NCT01524120 | University of Erlangen-Nürnberg Medical School | — |
| Completed | The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID NCT02135289 | Chinese University of Hong Kong | — |
| Completed | Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infu NCT01213680 | Pharmacosmos A/S | Phase 1 |
| Completed | Usefulness of Chromoendoscopy for the Early Detection of Colorectal Cancer Associated With Inflammatory Bowel NCT02543762 | Hospital Clinic of Barcelona | — |
| Completed | Improving Medication Adherence in Pediatric Inflammatory Bowel Disease NCT01536509 | Children's Hospital Medical Center, Cincinnati | N/A |
| Unknown | Telomere Length and Other Parameters of Telomere Dysfunction in PSC and Colitis NCT02247622 | Meir Medical Center | — |
| Completed | Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rh NCT02922192 | Biologics & Biosimilars Collective Intelligence Consortium | — |
| Completed | Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) NCT01496053 | Oslo University Hospital | Phase 2 / Phase 3 |
| Withdrawn | IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD NCT01438372 | Wayne State University | Phase 2 |
| Terminated | Double-balloon Colonoscopy to Increase Colonoscopy Completion Rate NCT01587872 | Sorlandet Hospital HF | N/A |
| Completed | Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients NCT01813500 | Boston Medical Center | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Ustekinumab Maintenance Therapy in Patients With Moderately to NCT01369355 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab NCT01981616 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | Real-time Diagnosis of Pseudopolyps During Colonoscopy NCT01557387 | University of Miami | — |
| Completed | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Crohn's Disease (A NCT01352221 | Shield Therapeutics | Phase 3 |
| Completed | SurgicAl Metabolic Phenotyping Longitudinal Evaluation Study NCT01378013 | Imperial College London | — |
| Withdrawn | Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Af NCT01293656 | Merck Sharp & Dohme LLC | — |
| Completed | Endomicroscopy in Primary Sclerosing Cholangitis Related Inflammatory Bowel Disease Surveillance NCT01880606 | Karolinska University Hospital | — |
| Completed | Safety and Efficacy Study of Oral Ferric Iron To Treat Iron Deficiency Anaemia in Quiescent Ulcerative Colitis NCT01340872 | Shield Therapeutics | Phase 3 |
| Completed | A Study to Evaluate the Safety and Efficacy of Ustekinumab in Patients With Moderately to Severely Active Croh NCT01369329 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Risk Factors for Colorectal Cancer in Patients With Inflammatory Bowel Disease Undergoing Surveillance: a Pros NCT01464151 | UMC Utrecht | — |
| Completed | A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients With Moderately to Se NCT01369342 | Janssen Research & Development, LLC | Phase 3 |
| Completed | Safety and Efficacy Extension Study of Iron Isomaltoside 1000 (Monofer®) in Subjects With Inflammatory Bowel D NCT01410435 | Pharmacosmos A/S | Phase 3 |
| Completed | MRI in Patients With Inflammatory Bowel Disease NCT02255019 | Copenhagen University Hospital at Herlev | — |
| Completed | Immunogenicity of Hepatitis A Vaccine in Inflammatory Bowel Disease (IBD) Patients NCT01341808 | Asan Medical Center | Phase 4 |
| Completed | A Trial of Multi-convergent Therapy for Functional Symptoms and Stress in Patients With Inflammatory Bowel Dis NCT01426568 | Cardiff and Vale University Health Board | N/A |
| Terminated | Comparison of Ferrisat vs Placebo in Anemia Associated to Inflammatory Bowel Disease During Anti-TNF Therapy NCT01428843 | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | Phase 3 |
| Not Yet Recruiting | Inflammatory Bowel Disease(IBD)Database NCT01266538 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Predictive Value of pCLE Findings in Pediatric IBD NCT02003859 | Scientific Center of Children's Health RAMS | — |
| Completed | A Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study of E6007 in Healthy Subjects NCT01221818 | Eisai Inc. | Phase 1 |
| Completed | Prognostic Indicators as Provided by the EPIC ClearView NCT01476995 | Epic Research & Diagnostics, Inc. | — |
| Unknown | A Brief Intervention to Improve Adherence in Teens With Inflammatory Bowel Disease NCT01237847 | Rosalind Franklin University of Medicine and Science | N/A |
| Unknown | Low-dose CT Using Iterative Reconstruction in Patients With Inflammatory Bowel Disease NCT01244386 | University College Cork | — |
| Unknown | Influence of Vitamin D on Inflammatory Bowel Disease Remission NCT01121796 | Hillel Yaffe Medical Center | N/A |
| Terminated | Prospective Randomized Trial of Anterograde Single Balloon Versus Spirus Enteroscopy NCT01853241 | Johns Hopkins University | — |
| Terminated | Gut Microbiota in the Healthy Population, Inflammatory Bowel Disease Patients, and Their Relatives NCT01140802 | Chinese University of Hong Kong | — |
| Completed | The Pediatric Intermed: A New Clinical Decision Making Tool NCT01781481 | Children's Hospital of Eastern Ontario | — |
| Completed | Evaluation of Reduced-volume PEG Bowel Preparation Administered the Same Day of Colonoscopy NCT01533090 | Catholic University of the Sacred Heart | N/A |
| Completed | A Trial of Iron Replacement in Patients With Iron Deficiency. NCT01067547 | Richard Fedorak | Phase 4 |
| Completed | Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease NCT01034358 | Mayo Clinic | Phase 4 |
| Completed | Respiratory Tract Inflammation in Children With Inflammatory Bowel Disease (IBD) NCT01000272 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Risk of Methicillin-resistant S.Aureus (MRSA) Infections in MRSA Carrier Under Introduction of Rapid MRSA Scre NCT01918813 | Chikara Tashiro | N/A |
| Terminated | An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease NCT01009281 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Confocal Endomicroscopy During Endoscopy NCT00988273 | University of Alberta | — |
| Completed | Evaluation of PillCam® Express Capsule Endoscopy Delivery System NCT01088646 | Medtronic - MITG | N/A |
| Completed | Telemedicine To Provide Inflammatory Bowel Disease Outpatient Care NCT01296841 | VA Palo Alto Health Care System | Phase 2 |
| Completed | MD2Me - Texting to Promote Chronic Disease Management NCT01253733 | Huang, Jeannie, M.D. | N/A |
| Completed | Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia NCT01017614 | Pharmacosmos A/S | Phase 3 |
| Completed | Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice NCT02322008 | Regionshospitalet Viborg, Skive | — |
| Terminated | NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease NCT00936585 | National Institutes of Health Clinical Center (CC) | N/A |
| Completed | Curcumin in Pediatric Inflammatory Bowel Disease NCT00889161 | Seattle Children's Hospital | Phase 1 |
| Completed | Effects of Relaxation Response Mind-body Intervention in Patients With IBS and IBD NCT02136745 | Massachusetts General Hospital | N/A |
| Completed | Vitamin D Supplementation in Crohn's Patients NCT00742781 | Penn State University | Phase 1 |
| Unknown | Assessment of Colonic Permeability by Confocal Laser Endomicroscopy NCT00883077 | Shandong University | — |
| Terminated | Fatty Liver in Inflammatory Bowel Disease (IBD) Patients NCT00855907 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Agaricus Blazei Murill (ABM) in Patients With Inflammatory Bowel Disease (IBD) NCT01106742 | Ullevaal University Hospital | Phase 2 |
| Completed | Maintenance Treatment of Iron Deficiency in IBD Patients NCT00810004 | Vifor Pharma | Phase 3 |
| Completed | Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients NCT00849368 | University of Zurich | Phase 1 |
| Completed | Healthy Normal Single Ascending Dose and Crohn's Patient Multiple Ascending Dose NCT00868660 | Zealand Pharma | Phase 1 |
| Completed | FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR NCT00810030 | Vifor Pharma | Phase 3 |
| Completed | Open Label Study for Adults With Pyoderma Gangrenosum and Inflammatory Bowel Disease NCT00791557 | University Hospitals Cleveland Medical Center | N/A |
| Terminated | The Use of Oral Budesonide and Rectal Hydrocortisone for the Treatment of Active Ulcerative Colitis NCT00805285 | University of Maryland, Baltimore | Phase 2 |
| Completed | Micro Ribonucleic Acid (RNA) as Cholinergic Tone and Inflammatory Regulator in Inflammatory Bowel Disease NCT00734331 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Prevalence of Inflammatory Bowel Disease in Patients With Perianal Disease NCT00972088 | Bikkur Holim Hospital | N/A |
| Completed | Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy NCT00727636 | Boston Children's Hospital | N/A |
| Completed | Randomized, Placebo-controlled Trial of Lubiprostone as a Preparation for Capsule Endoscopy NCT00746395 | University of South Alabama | Phase 4 |
| Terminated | Vitamin D Levels in Children With IBD NCT00621257 | Boston Children's Hospital | N/A |
| Completed | Understanding and Treating Neuropsychiatric Symptoms of Pediatric Physical Illness NCT00769353 | University of Pittsburgh | N/A |
| Completed | The Home Telemanagement (UC HAT) Trial for Patients With Ulcerative Colitis NCT00620126 | University of Maryland, Baltimore | Phase 3 |
| Completed | Gene Regulation by Thiazolidinediones NCT00567593 | James Lewis | Phase 4 |
| Completed | Managing Inflammatory Bowel Disease NCT00679003 | University of Washington | N/A |
| Completed | Reducing Depressive Symptoms in Physically Ill Youth NCT00534911 | University of Pittsburgh | N/A |
| Completed | Inflammatory Bowel Disease Research Registry NCT00574028 | University of California, Irvine | — |
| Recruiting | A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel D NCT00904878 | University of California, San Francisco | — |
| Completed | Levels of the Stat4 Alpha and Stat4 Beta Isoforms in PBMCs From Patients With Crohn's Disease and Ulcerative C NCT00586599 | Indiana University | N/A |
| Completed | Ulcerative Colitis Relapse Prevention Trial, Hypnosis NCT00798642 | Northwestern University | N/A |
| Unknown | Interactions Between Immune Cells of Intestinal Mucosa or Peripheral Blood With the Extracellular Matrix in In NCT00915044 | Tel-Aviv Sourasky Medical Center | — |
| Completed | Immunogenicity of HPV Vaccine in Immunosuppressed Children NCT02263703 | The University of New South Wales | Phase 3 |
| Withdrawn | Milk-derived Gangliosides for Inflammatory Bowel Disease NCT02139709 | University of Alberta | Phase 1 |
| Completed | Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Di NCT00658827 | Janssen Biotech, Inc. | — |
| Completed | Sirolimus for Autoimmune Disease of Blood Cells NCT00392951 | Children's Hospital of Philadelphia | Phase 1 / Phase 2 |
| Completed | Open-Label, Long-term Balsalziade Disodium Tablet Ulcerative Colitis Study NCT00486031 | Bausch Health Americas, Inc. | Phase 3 |
| Terminated | Colon Investigation - Factors Determining Choice of Procedure NCT00423345 | Sykehuset Telemark | — |
| Completed | Dietary Treatment of Crohn's Disease NCT00343642 | Rush University Medical Center | Phase 1 / Phase 2 |
| Completed | Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560) NCT00723840 | Merck Sharp & Dohme LLC | — |
| Completed | Telomere Repair Gene Mutation in Inflammatory Bowel Disease NCT00353639 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Balsalazide Disodium vs. Mesalamine in Mildly to Moderately Active Ulcerative Colitis NCT00408174 | Bausch Health Americas, Inc. | Phase 3 |
| Terminated | Non-invasive Imaging of GI Inflammation Using Microbubble Contrast Enhanced Ultrasonography NCT00591669 | University of Virginia | N/A |
| Completed | Value of Fecal Calprotectin NCT00577928 | Indiana University | — |
| Completed | Prevalence of Lymphoma in IBD NCT00577538 | Indiana University | — |
| Completed | Safety and Efficacy of AST-120 in Mild to Moderate Crohn's Patients With Fistulas NCT00321412 | Ocera Therapeutics | Phase 3 |
| Unknown | Differences in Human Germinal Center B Cell Selection Revealed by Analysis of IgVH Gene Hypermutation and Line NCT00291681 | Sheba Medical Center | — |
| Completed | Surgical Decision Making Among People With Inflammatory Bowel Disease NCT00438711 | University of North Carolina, Chapel Hill | — |
| Completed | The Influence of 5-Aminosalicylates on Thiopurine Metabolite Levels NCT00167882 | Amsterdam UMC, location VUmc | Phase 4 |
| Completed | Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease NCT00829595 | Cedars-Sinai Medical Center | N/A |
| Completed | Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safe NCT00232258 | Sanofi | Phase 2 |
| Completed | Infectious Agents in Pediatric Crohn's NCT00237055 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | NPDT Evaluation in Children With CFTR and (PSC) NCT00179439 | Beth Israel Deaconess Medical Center | — |
| Completed | A Randomized Controlled Trial of VSL#3 for the Prevention of Endoscopic Recurrence Following Surgery for Crohn NCT00175292 | University of Alberta | Phase 3 |
| Completed | Genetic Studies of Inflammatory Bowel Disease NCT00340444 | National Human Genome Research Institute (NHGRI) | — |
| Completed | Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease NCT00215020 | Boston Children's Hospital | — |
| Active Not Recruiting | Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS) NCT01169194 | Johns Hopkins University | — |
| Completed | Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis NCT00073047 | Facet Biotech | Phase 2 |
| Withdrawn | Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease NCT00783575 | Medical College of Wisconsin | — |
| Terminated | Clotrimazole Enemas for Pouchitis in Children and Adults NCT00061282 | Web | Phase 1 / Phase 2 |
| Completed | A Trial of Rosiglitazone for Ulcerative Colitis NCT00065065 | James Lewis | Phase 2 |